Holen Sie sich die Stockscreener-App
0.3464
7.38%
-0.0276
Handel nachbörslich:
.35
0.0036
+1.04%
Adial Pharmaceuticals Inc Aktie (ADIL) Neueste Nachrichten
What’s the fair value of Adial Pharmaceuticals Inc. stockTrend Reversal & Safe Entry Zone Tips - khodrobank.com
How sentiment analysis helps forecast Adial Pharmaceuticals Inc.Price Action & Real-Time Volume Trigger Notifications - Newser
What data driven models say about Adial Pharmaceuticals Inc.’s futureJuly 2025 Short Interest & Safe Capital Growth Stock Tips - Newser
Key metrics from Adial Pharmaceuticals Inc.’s quarterly dataEarnings Risk Summary & Community Verified Watchlist Alerts - Newser
Combining machine learning predictions for Adial Pharmaceuticals Inc.July 2025 Fed Impact & Real-Time Chart Pattern Alerts - Newser
Using Python tools to backtest Adial Pharmaceuticals Inc. strategies2025 Top Decliners & Free Low Drawdown Momentum Trade Ideas - Newser
Is Adial Pharmaceuticals Inc. stock a good pick for beginnersDividend Hike & Verified Chart Pattern Trade Signals - khodrobank.com
What are analysts’ price targets for Adial Pharmaceuticals Inc.Trade Exit Report & Fast Moving Stock Watchlists - khodrobank.com
Published on: 2025-09-03 12:27:20 - Newser
Is Adial Pharmaceuticals Inc. stock poised for growth2025 EndofYear Setup & Verified Chart Pattern Signals - Newser
Using data models to predict Adial Pharmaceuticals Inc. stock movementEarnings Miss & Advanced Technical Signal Analysis - Newser
Using flow based indicators on Adial Pharmaceuticals Inc.Portfolio Growth Summary & Weekly Top Gainers Alerts - Newser
Adial Pharmaceuticals receives 180-day Nasdaq extension to meet $1 bid price - Investing.com
Adial Pharmaceuticals granted a 180 calendar day extension by Nasdaq to regain compliance with the minimum bid price rule - MarketScreener
Adial Pharmaceuticals Receives 180-Day Extension to Regain Nasdaq Compliance with Minimum Bid Price Requirement - Quiver Quantitative
Nasdaq Grants Biotech Adial Pharmaceuticals Final 180-Day Extension to Maintain Market Listing - Stock Titan
Adial Pharmaceuticals Granted a 180 Calendar Day Extension - GlobeNewswire
Adial Pharmaceuticals Receives 180-Day Nasdaq Extension to Regain Minimum Bid Price Compliance - AInvest
Long term hold vs stop loss in Adial Pharmaceuticals Inc.2025 Key Lessons & Safe Capital Allocation Plans - Newser
Applying big data sentiment scoring on Adial Pharmaceuticals Inc.Weekly Trade Analysis & Risk Controlled Swing Alerts - Newser
Published on: 2025-09-03 02:15:20 - Newser
Combining machine learning predictions for Adial Pharmaceuticals IncQuarterly Portfolio Summary & Proven Capital Preservation Tips - Newser
How to interpret RSI for Adial Pharmaceuticals Inc. stockJuly 2025 Gainers & Stepwise Trade Signal Implementation - Newser
Market reaction to Adial Pharmaceuticals Inc.’s recent newsJuly 2025 Fed Impact & Stock Portfolio Risk Management - Newser
Is Adial Pharmaceuticals Inc. stock a smart retirement pickForecast Cut & Community Shared Stock Ideas - khodrobank.com
What earnings revisions data tells us about Adial Pharmaceuticals Inc.July 2025 Earnings & AI Enhanced Market Trend Forecasts - Newser
Adial Pharmaceuticals Inc. stock trend forecast2025 Momentum Check & Consistent Profit Trading Strategies - Newser
How to build a custom watchlist for Adial Pharmaceuticals Inc.Weekly Loss Report & Reliable Intraday Trade Plans - Newser
Advanced analytics toolkit walkthrough for Adial Pharmaceuticals Inc.July 2025 Fed Impact & Fast Gain Swing Trade Alerts - Newser
Will Adial Pharmaceuticals Inc. rebound enough to break evenMarket Sentiment Review & Weekly High Return Stock Forecasts - Newser
Is Adial Pharmaceuticals Inc. showing signs of accumulationJuly 2025 Pullbacks & Risk Adjusted Buy/Sell Alerts - Newser
Is Adial Pharmaceuticals Inc. stock a good dividend stockJuly 2025 PreEarnings & Real-Time Volume Analysis Alerts - khodrobank.com
Key resistance and support levels for Adial Pharmaceuticals Inc.July 2025 Summary & Free Safe Entry Trade Signal Reports - Newser
Should value investors consider Adial Pharmaceuticals Inc.2025 Market Outlook & Low Volatility Stock Recommendations - khodrobank.com
All You Need to Know About Adial Pharmaceuticals (ADIL) Rating Upgrade to Buy - MSN
Adial Pharmaceuticals Upgrade to Buy: Harnessing Earnings Estimate Revisions for Investment Success - AInvest
Ichimoku Cloud Indicates Uncertainty Around Adial Pharmaceuticals Inc.Jobs Report & Free High Return Stock Watch Alerts - beatles.ru
Technical analysis overview for Cyclacel Pharmaceuticals Inc. stockJuly 2025 Chart Watch & High Accuracy Investment Entry Signals - Newser
Published on: 2025-09-01 12:16:11 - beatles.ru
What is the earnings history of Adial Pharmaceuticals Inc.Quarterly Profit Summary & Weekly Consistent Profit Watchlists - khodrobank.com
What earnings revisions data tells us about Adial Pharmaceuticals IncPortfolio Update Report & Verified Momentum Watchlists - Newser
Quant Models Detect Momentum Reversal in Adial Pharmaceuticals Inc.2025 Volatility Report & Real-Time Stock Movement Alerts - beatles.ru
Will Adial Pharmaceuticals Inc. stock recover after recent dropEarnings Overview Summary & Short-Term Swing Trade Alerts - Newser
How to build a dashboard for Adial Pharmaceuticals Inc. stockWeekly Market Summary & Fast Entry High Yield Tips - Newser
Is MVIS stock bottoming outJuly 2025 Opening Moves & AI Based Buy/Sell Signal Reports - Newser
Multi asset correlation models including Adial Pharmaceuticals Inc.Trade Analysis Summary & Safe Entry Trade Reports - Newser
Is Adial Pharmaceuticals Inc. still worth holding after the dipJuly 2025 Gainers & Technical Pattern Based Buy Signals - Newser
Volatility clustering patterns for Adial Pharmaceuticals Inc.2025 Trade Ideas & Fast Gain Swing Alerts - Newser
Developing predictive dashboards with aTyr Pharma Inc. dataJuly 2025 PostEarnings & Consistent Return Investment Signals - Newser
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):